Ann Dermatol.  2011 Aug;23(3):412-414. 10.5021/ad.2011.23.3.412.

A Case of Cutaneous Side Effect of Methotrexate Mimicking Behcet's Disease

• Lee HJ
• Hong SK
• Seo JK
• Lee D
• Sung HS

• KMID: 2171943
• DOI: http://doi.org/10.5021/ad.2011.23.3.412

Abstract

Methotrexate (MTX) is an antimetabolite which interferes with DNA synthesis, and it is used for the treatment of moderate to severe psoriasis, atopic dermatitis and a wide variety of cutaneous diseases. Although many adverse effects of MTX, including cutaneous ulcerations, have been documented, multifocal mucosal ulceration mimicking Behcet's disease has not been reported. In our case, a 63-year-old female presented with oral, vaginal ulcer and multiple purpuric patches on both legs. Considering patient's clinical course and histopathologic findings, we presumed that these reactions may be the side effect of MTX administered for treatment of necrotizing scleritis. Herein we report the cutaneous side effect of MTX that manifested clinically like Behcet's disease.

Keyword

Adverse reaction; Behcet's disease; Methotrexate

MeSH Terms

Dermatitis, Atopic
DNA
Female
Humans
Leg
Methotrexate
Middle Aged
Psoriasis
Scleritis
Ulcer
DNA
Methotrexate

Figure

• 

  Fig. 1 Multiple erythematous erosions in the oral cavity.

• 

  Fig. 2 Erythematous ulcers on the lower extremities.

• 

  Fig. 3 (A) Multiple erosive erythematous to purpuric crusted patches and papules on both legs. (B) Flattening of rete ridges, dyskeratotic keratinocytes in the epidermis, and vacuolar degeneration and hyperpigmentation of basal cell layer. In the dermis, mild vascular proliferation and perivascular infiltration of lymphocytes were demonstrated. No evidence of vasculitis was seen (A: H&E ×100).

Reference

1. Kazlow DW, Federgrun D, Kurtin S, Lebwohl MG. Cutaneous ulceration caused by methotrexate. J Am Acad Dermatol. 2003. 49:S197–S198.

2. Lebwohl M, Ting PT, Koo JY. Psoriasis treatment: traditional therapy. Ann Rheum Dis. 2005. 64:Suppl 2. ii83–ii86.

3. Roenigk HH Jr, Auerbach R, Maibach HI, Weinstein GD. Methotrexate in psoriasis: revised guidelines. J Am Acad Dermatol. 1988. 19:145–156.

4. Varela CR, McNamara J, Antaya RJ. Acral erythema with oral methotrexate in a child. Pediatr Dermatol. 2007. 24:541–546.

5. Pearce HP, Wilson BB. Erosion of psoriatic plaques: an early sign of methotrexate toxicity. J Am Acad Dermatol. 1996. 35:835–838.

6. Lawrence CM, Dahl MG. Two patterns of skin ulceration induced by methotrexate in patients with psoriasis. J Am Acad Dermatol. 1984. 11:1059–1065.

7. Kaplan DL, Olsen EA. Erosion of psoriatic plaques after chronic methotrexate administration. Int J Dermatol. 1988. 27:59–62.

8. Sainz de la Maza M, Jabbur NS, Foster CS. Severity of scleritis and episcleritis. Ophthalmology. 1994. 101:389–396.